how is retatrutide different from semaglutide vs. Tirzepatide vs. Comparing the Big 3, Semaglutide,

Recent research has linked GLP-1s to cancer prevention

SIRT1 has neuroprotective effects through modulation of the fate precursor cells, inhibition of p53, and attenuation of axonal degeneration

Starting at 200 lbs, the average projection is approximately 48 lbs lost, landing near 152 lbs

Among the 101 participants receiving the highest 4.5 mg/week dose, the most frequently reported side effects included: Indigestion: 4% Headache: 7% Loose stools: 7% Vomiting: 8% Allergic reactions: 10% Fatigue: 20% Constipation: 21% Injection site reactions: 43% Nausea: 47% Serious side effects in this phase 2 trial occurred in 2% to 7% of the cagrilintide groups, compared to 4% in the liraglutide group and 3% in the placebo group